
Transapical transcatheter aortic valve replacement with the balloon expandable aortic bioprosthetic valve in high risk patients with severe aortic stenosis: Intermediate-term results from the register of the clinic of cardiac surgery
Author(s) -
Michal Hulman,
Martin Borggrefe,
Panagiotis Artemiou,
Ivo Gašparovič,
Vladan Hudec,
J. Hasakova
Publication year - 2019
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2019_074
Subject(s) - medicine , ejection fraction , stenosis , euroscore , ventricle , cardiology , balloon , surgery , cardiac surgery , valve replacement , aortic valve stenosis , aortic valve , aortic valvuloplasty , aortic valve replacement , heart failure
The purpose of this study is to report our experience in performing transapical (TA) TAVR with a balloon-expandable valve only by cardiac surgeons, with on site interventional cardiology support.